Articles

Poll

Podcasts

Slideshows

Videos

Brown discusses a destigmatised future of obesity management in patients with kidney failure. 


Destigmatizing Obesity in Kidney Failure Patients Seeking Transplants, With Adrian Brown, PhD

Willingness to pursue living kidney donation is shaped by relationships, health, and a multidisciplinary approach, not just finances.

Living Donor Donation Works When Relationships Matter With Mary Roberts, PhD

Systematic review identifies patient and clinician barriers to obesity management before kidney transplantation, with Adrian Brown, PhD.

Barriers to Obesity Management in Kidney Failure Before Transplantation

Rare kidney diseases are hard to detect early, but precision therapies and updated guidelines offer new ways to improve patient outcomes.


Rare Kidney Disease: Advances in Early Detection, Precision Therapies, and Clinical Practice Shifts With Swati Arora, MD

An audio recap of the top 5 stories in healthcare news from the week of 02/15-02/21.

HCPLive 5 Stories in Under 5: Week of 02/15

Survey of 600 US relatives finds donor–recipient closeness and expected life extension drive living kidney donation more than financial concerns.

Donor–Recipient Closeness, Perceived Life Extension Drive Living Kidney Donation Decisions, With Mary Roberts, PhD

1 year into real-world use, 4 clinicians discuss how semaglutide is transforming the endocrinology, nephrology, and cardiology landscape.


1 Year After CKD Approval, Semaglutide Transforms Diabetes, Kidney, and Heart Care

CKM syndrome affects nearly 90% of US adults, highlighting the need to manage cardiovascular, kidney, and metabolic risk together.


Why Cardiovascular, Kidney, Metabolic Risk Must Be Managed Together, With Janani Rangaswami, MD, FAHA

Targeting CD28 and CD154 pathways, dual blockade with belatacept and dazodalibep offers potential to improve adherence in kidney transplant recipients.



Dual Costimulation Blockade May Eliminate Daily Oral Immunosuppression in Kidney Transplant

Targeting CD28 and CD154 pathways, dual blockade with belatacept and dazodalibep offers a new mechanistic approach in kidney transplant care.

Mechanistic Rationale for Dual Costimulation Blockade, Belatacept, Dazodalibep in Kidney Transplantation

C3 Glomerulopathy

The HCPLive C3 glomerulopathy page is a resource for medical news and expert insights on C3G. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in C3G, and more.

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Focal Segmental Glomerulosclerosis

The HCPLive focal segmental glomerulosclerosis page is a resource for medical news and expert insights on FSGS. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in FSGS, and more. 

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Nephrology